Latest news with #NipponIndiaMF
Time of India
04-08-2025
- Business
- Time of India
Nippon MF plans simpler schemes for new investors
. Leh: Nippon India MF is exploring the launch of simple, easy-to-understand mutual fund products for first-time investors in remote areas. At the launch of the fund house's Leh branch - the first physical presence for any asset management company in Ladakh - CEO Sundeep Sikka said that though people in the region were earning well, they invested in unregulated informal products due to limited financial literacy. The move aims to boost mutual fund participation in a region that accounts for just over 0.1% of India's MF assets. It sees growth potential in Ladakh's rising income, expanding govt jobs, and low MF-to-GDP ratio (4% vs India's 20%). The initiative also aims to prevent mis-selling by educating both investors and distributors. "We have seen many govt employees being hired, and income from tourism will rise. So, whatever is the per capita income here today, I feel this region will grow faster than the rest of the country on the back of a low base," said Sikka. (The writer was in Leh at the invitation of Nippon India MF) Stay informed with the latest business news, updates on bank holidays and public holidays . Discover stories of India's leading eco-innovators at Ecopreneur Honours 2025
&w=3840&q=100)
Business Standard
20-06-2025
- Business
- Business Standard
Nippon India MF, BlackRock, others buy 10% stake in Sai Life for ₹1,505 cr
Nippon India Mutual Fund, BlackRock, Societe Generale, Morgan Stanley and others on Friday collectively bought a 10 per cent stake in Sai Life Sciences from US-based asset manager TPG for Rs 1,505 crore through open market transactions. Besides, Axis Mutual Fund (MF), Aditya Birla Sun Life MF, Invesco MF, Norway's Government Pension Fund Global, German multinational Allianz's arm Pimco, Axis Max Life Insurance, HDFC MF, Ghisallo Master Fund LP, UTI MF, DSP MF were among the buyers of Sai Life Sciences shares. These entities picked up more than 2.08 crore equity shares or 10 per cent stake in Hyderabad-based Sai Life Sciences, as per the block deal data on the BSE. The transaction, valued at around Rs 1,504.75 crore, was executed at an average price of Rs 722 apiece. Meanwhile, Nippon India MF picked up 49.86 lakh shares or 2.39 per cent holding in Sai Life Sciences. After the stake buy, Nippon India MF's stake in the company rose to 4.88 per cent from 2.48 per cent. Meanwhile, global asset manager TPG through its affiliate TPG Asia VII SF offloaded the equal number of shares in 25 tranches at the same price. Following the stake sale, TPG's holding in Sai Life Sciences declined to 14.73 per cent from 24.73 per cent. Shares of Sai Life Sciences rose 5.03 per cent to close at Rs 765.85 apiece on the BSE. In December last year, Sai Life Sciences raised Rs 3,043 crore through its initial public offering and the shares of the company made a stellar debut on the bourses. Sai Life Sciences provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities (NCE) to global pharmaceutical innovator companies and biotechnology firms.
